1. Home
  2. LUCD
  3. LUCD News

Latest Lucid Diagnostics Inc. (LUCD) News on July 1, 2025

Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test
LUCD

PR Newswire

13 days ago

Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test

LUCD

MT Newswires

a month ago

Lucid Diagnostics to Join Russell 2000, Russell 3000 Indexes

Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes
LUCD

PR Newswire

a month ago

Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes

LUCD

MT Newswires

a month ago

Lucid Diagnostics Files Shelf Registration for Secondary Sale of 37 Million Shares by Convertible Note Holders

PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results
LUCD

PR Newswire

2 months ago

PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results

LUCD

GuruFocus.com

2 months ago

Lucid Diagnostics Inc (LUCD) Q1 2025 Earnings Call Highlights: Strategic Growth Amid Revenue ...

Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Lags Revenue Estimates
LUCD

Zacks

2 months ago

Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Lags Revenue Estimates

Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results
LUCD

PR Newswire

2 months ago

Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results

Will Lucid Diagnostics Inc. (LUCD) Report Negative Earnings Next Week? What You Should Know
LUCD

Zacks

2 months ago

Will Lucid Diagnostics Inc. (LUCD) Report Negative Earnings Next Week? What You Should Know

PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025
LUCD

PR Newswire

2 months ago

PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025
LUCD

PR Newswire

2 months ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025

NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD
LUCD

PR Newswire

2 months ago

NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD

LUCD

GuruFocus.com

2 months ago

Lucid Diagnostics Inc (LUCD) Q4 2024 Earnings Call Highlights: Record Test Volumes and ...

LUCD

MT Newswires

3 months ago

Lucid Diagnostics Closes Common Stock Offering

Lucid Diagnostics Announces Closing of Public Offering of Common Stock
LUCD

PR Newswire

3 months ago

Lucid Diagnostics Announces Closing of Public Offering of Common Stock

LUCD

MT Newswires

3 months ago

Lucid Diagnostics Shares Fall After Pricing Stock Offering

Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
LUCD

PR Newswire

3 months ago

Lucid Diagnostics Announces Pricing of Public Offering of Common Stock

LUCD

MT Newswires

3 months ago

Lucid Diagnostics Plans Public Offering of Common Stock

Lucid Diagnostics Announces Proposed Public Offering of Common Stock
LUCD

PR Newswire

3 months ago

Lucid Diagnostics Announces Proposed Public Offering of Common Stock

Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
LUCD

PR Newswire

3 months ago

Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology
LUCD

PR Newswire

3 months ago

Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology

PAVmed Inc (PAVM) Q4 2024 Earnings Call Highlights: Strategic Growth and Financial Stability
LUCD

GuruFocus.com

3 months ago

PAVmed Inc (PAVM) Q4 2024 Earnings Call Highlights: Strategic Growth and Financial Stability

LUCD

Thomson Reuters StreetEvents

3 months ago

Q4 2024 PAVmed Inc Earnings Call

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
LUCD

PR Newswire

3 months ago

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Lucid Diagnostics Inc. (LUCD) Reports Q4 Loss, Lags Revenue Estimates
LUCD

Zacks

3 months ago

Lucid Diagnostics Inc. (LUCD) Reports Q4 Loss, Lags Revenue Estimates

Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
LUCD

PR Newswire

3 months ago

Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Lucid Diagnostics Inc (LUCD) Q4 2024 Earnings Report Preview: What To Expect
LUCD

GuruFocus.com

3 months ago

Lucid Diagnostics Inc (LUCD) Q4 2024 Earnings Report Preview: What To Expect

Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer Screening
LUCD

PR Newswire

3 months ago

Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer Screening

Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication
LUCD

PR Newswire

3 months ago

Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication

Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA Test
LUCD

PR Newswire

4 months ago

Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA Test

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025
LUCD

PR Newswire

4 months ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025

Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering
LUCD

PR Newswire

4 months ago

Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering

LUCD

MT Newswires

4 months ago

Lucid Diagnostics Prices $15.3 Million Direct Offering

Lucid Diagnostics Announces $15.3 Million Registered Direct Offering
LUCD

PR Newswire

4 months ago

Lucid Diagnostics Announces $15.3 Million Registered Direct Offering

Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard® in At-Risk Patients without Symptomatic GERD
LUCD

PR Newswire

4 months ago

Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard® in At-Risk Patients without Symptomatic GERD

Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement
LUCD

PR Newswire

4 months ago

Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement

Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health
LUCD

PR Newswire

4 months ago

Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health

PAVmed Regains Compliance with Nasdaq Stockholders' Equity Requirement
LUCD

PR Newswire

4 months ago

PAVmed Regains Compliance with Nasdaq Stockholders' Equity Requirement

Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
LUCD

PR Newswire

5 months ago

Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume
LUCD

PR Newswire

6 months ago

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume

Lucid Inks New Partnership With VITALExam: Stock to Gain?
LUCD

Zacks

6 months ago

Lucid Inks New Partnership With VITALExam: Stock to Gain?

LUCD

MT Newswires

6 months ago

Lucid Diagnostics Secures 180-Day Extension to Regain Compliance With Nasdaq Listing Rules

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
LUCD

PR Newswire

6 months ago

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters
LUCD

PR Newswire

6 months ago

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication
LUCD

PR Newswire

7 months ago

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones
LUCD

PR Newswire

7 months ago

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones

Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test
LUCD

PR Newswire

7 months ago

Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test

Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
LUCD

PR Newswire

7 months ago

Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

LUCD

Thomson Reuters StreetEvents

8 months ago

Q3 2024 PAVmed Inc Earnings Call

PAVmed Inc (PAVM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Restructuring
LUCD

GuruFocus.com

8 months ago

PAVmed Inc (PAVM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Restructuring

PAVmed Provides Business Update and Third Quarter 2024 Financial Results
LUCD

PR Newswire

8 months ago

PAVmed Provides Business Update and Third Quarter 2024 Financial Results

LUCD

GuruFocus.com

8 months ago

Lucid Diagnostics Inc (LUCD) Q3 2024 Earnings Call Highlights: Record Revenue Growth Amid ...

Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial Results
LUCD

PR Newswire

8 months ago

Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial Results

Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication
LUCD

PR Newswire

8 months ago

Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication

Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers
LUCD

PR Newswire

8 months ago

Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers

PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024
LUCD

PR Newswire

8 months ago

PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 13, 2024
LUCD

PR Newswire

8 months ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 13, 2024

Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA Test
LUCD

PR Newswire

9 months ago

Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA Test

Castle Biosciences price target raised to $40 from $35 at BTIG
LUCD

TipRanks

9 months ago

Castle Biosciences price target raised to $40 from $35 at BTIG

Lucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual Summit
LUCD

PR Newswire

9 months ago

Lucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual Summit

Lucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024
LUCD

PR Newswire

9 months ago

Lucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024

Lucid Diagnostics Holds Inaugural #CheckYourFoodTube Precancer Testing Event for Former NFL Players
LUCD

PR Newswire

9 months ago

Lucid Diagnostics Holds Inaugural #CheckYourFoodTube Precancer Testing Event for Former NFL Players

American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer Test
LUCD

PR Newswire

9 months ago

American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer Test

PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements
LUCD

PR Newswire

9 months ago

PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements

Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World Congress
LUCD

PR Newswire

10 months ago

Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World Congress

Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health
LUCD

PR Newswire

10 months ago

Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health

Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and Cancer
LUCD

PR Newswire

10 months ago

Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and Cancer

LUCD

Thomson Reuters StreetEvents

a year ago

Q2 2024 PAVmed Inc Earnings Call

The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal Cancer
LUCD

PR Newswire

a year ago

The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal Cancer

PAVmed Provides Business Update and Second Quarter 2024 Financial Results
LUCD

PR Newswire

a year ago

PAVmed Provides Business Update and Second Quarter 2024 Financial Results

LUCD

MT Newswires

a year ago

Lucid Diagnostics Shares Rise Following Q2 Results

Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results
LUCD

PR Newswire

a year ago

Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results

Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing Event
LUCD

PR Newswire

a year ago

Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing Event

Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing
LUCD

PR Newswire

a year ago

Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing

Lucid Diagnostics to Participate in Upcoming Investor Conferences
LUCD

PR Newswire

a year ago

Lucid Diagnostics to Participate in Upcoming Investor Conferences

PAVmed to Hold a Business Update Conference Call and Webcast on August 13, 2024
LUCD

PR Newswire

a year ago

PAVmed to Hold a Business Update Conference Call and Webcast on August 13, 2024

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 12, 2024
LUCD

PR Newswire

a year ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 12, 2024

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume
LUCD

PR Newswire

a year ago

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume

Lucid Diagnostics Launches New Corporate Website
LUCD

PR Newswire

a year ago

Lucid Diagnostics Launches New Corporate Website

Lucid Diagnostics (LUCD) Reports Positive ESOGUARD BE-1 Data
LUCD

Zacks

a year ago

Lucid Diagnostics (LUCD) Reports Positive ESOGUARD BE-1 Data

Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population
LUCD

PR Newswire

a year ago

Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population

4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer Testing
LUCD

PR Newswire

a year ago

4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer Testing

LUCD

Thomson Reuters StreetEvents

a year ago

Q1 2024 PAVmed Inc Earnings Call

LUCD

GuruFocus.com

a year ago

Lucid Diagnostics Inc (LUCD) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...

PAVmed Provides Business Update and First Quarter 2024 Financial Results
LUCD

PR Newswire

a year ago

PAVmed Provides Business Update and First Quarter 2024 Financial Results

Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results
LUCD

PR Newswire

a year ago

Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results

Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall
LUCD

PR Newswire

a year ago

Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall

Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors
LUCD

PR Newswire

a year ago

Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024
LUCD

PR Newswire

a year ago

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024

Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing
LUCD

PR Newswire

a year ago

Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing

Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness Month
LUCD

PR Newswire

a year ago

Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness Month

Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
LUCD

PR Newswire

a year ago

Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

PAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Call Transcript
LUCD

Insider Monkey

a year ago

PAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Call Transcript

LUCD

Thomson Reuters StreetEvents

a year ago

Q4 2023 PAVmed Inc Earnings Call

Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2023 Earnings Call Transcript
LUCD

Insider Monkey

a year ago

Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2023 Earnings Call Transcript

LUCD

Thomson Reuters StreetEvents

a year ago

Q4 2023 Lucid Diagnostics Inc Earnings Call

PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results
LUCD

PR Newswire

a year ago

PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results

Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results
LUCD

PR Newswire

a year ago

Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results

Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population
LUCD

PR Newswire

a year ago

Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population

Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference
LUCD

PR Newswire

a year ago

Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference

Share on Social Networks: